Products

Alimentary Tract & Metabolism

Antiinfectives for Syetemic Use

Antiparasitic Products

Blood & Blood forming Organs

Cardiovascular System

Dermatologicals

Musculo-Skeletal System

Nervous System

Respiratory System

Sensory Organs

New Products


Helmadol Susp. (Albendazole)




Pharmaceutical Form
Suspension for oral use.

COMPOSITION
20 ml of suspension contains
Albendazole     400 mg.
 
THERAPEUTIC INDICATIONS
Helmadol is a highly effective antiparasitic agent of a polyvalent action; the majority of helminthiases may be treated with this agent:
- nematodosis:
Ascariasis, disease-producing factor – nematode helminth Ascaris lumbricoidesl;
Trichocefales (whipworm), disease-producing factor – nematode helminth Trichocephalus trichiurus;
Enterobiasis (pinworms), disease-producing factor - nematode helminth Enterobius vermicularis;
Ankylostomiasis, disease-producing factors – Ancylostoma duodenale and Necator americanus; trichinosis, disease-producing factors – meat porkworms;
Toxocariasis, disease-producing factor - Toxocara canis, dog parasite;
Strogiloidos (dwarf threadworm), disease-producing factor – nematode helminth Strongiloides strcoralis,
And also mixed invasions;
- Tissue cestodosis:
Cysticercosis (disease-producing factor - �ysticercus cellulosus, larval stage of armed tapeworm);  
Hydatid disease of liver, lungs, peritoneum, caused by larval stage of dog tapeworm (Echinococcus granulosus),
Also the drug is applied as an additive agent in surgical treatment of alveolar echinococcosis.
 
CONTRAINDICATIONS
- Hypersensitivity to any drug ingredients and other derivatives of benzimidazole;
- Eye retina pathology;
- Pregnancy;
- Lactation (breast feeding).
 
ADVERSE EFFECTS
Effects on digestive system: abdominal pains, nausea, vomiting.
Effects on cardiovascular system: elevation of blood pressure.
Effects on central nervous system: headache and dizziness.
Effects on urinary excretion system: changes of indices of renal function (acute renal impairment).
Dermatologic reactions: itching, skin eruption and other allergic reactions.
 
DOSAGE AND ADMINISTRATION
Oral administration during or after meal intake. Special preparation and diet is not required.
Use a calibrated 13-ml dosage cap (10 ml, 5 ml and 2.5 ml) for dosing of suspension.
Choose a drug formulation individually depending on convenience of a drug and tolerance of its compounds.
Determine a dose individually depending on invasion type, patient’s body weight. The maximum daily dose is 800 mg.
Ascaridiasis, trichocefales:  for patients with body weight of 60 kg and more  -  400 mg daily as a single dose or 200 mg 2 times a day; for patients with body weight less than 60 kg  – 15 mg/kg daily divided into two doses.
Enterobiasis: 5 mg/kg of body weight as a single dose. Repeat the scheme in 14 days.
Strongyloidiasis, ankylostomiasis 10 mg/kg of body weight daily within 3 days. Repeat the scheme in 14 days.
Trichinosis: 10 mg/kg of body weight daily divided into two doses within 7-10 days.
Toxocariasis. 10 mg/kg of body weight daily divided into two doses after meal within 10 days. Repeat the scheme in 14 days or a month.
Hydatid echinococcosis. Treatment is possible if laboratory indices are within limits. 10 mg/kg of body weight daily divided into two or three doses. Therapy course is 3 cycles of 28 days with 14 day’s interval.
Cysticercosis: 15 mg/kg of body weight daily divided into three doses. The therapy course is 28-30 days.
 
OVERDOSAGE
Symptoms: enhancement of adverse reactions is reported.
Therapy: gastric lavage, prescription of activated charcoal, symptomatic therapy.
 
DRUG INTERACTOINS
Dexamethasone and cimetidine increases blood Albendazole sulfoxide concentration.
 
PRECAUTIONS
Use Helmadol with cautious in case of hepatic impairment.
Prior treatment make pregnancy test in women of childbearing age. Reliable contraception is required during therapy.
 
Effects on ability to drive and operate with mechanisms
The drug does not cause changes of patient’s psychophysical state, does not influence on ability for driving and working with complicated mechanisms.
 
PREGNANCY AND LACTATION
Helmadol is contraindicated during pregnancy and lactation (breast-feeding).
 
MANUFACTURED FORM
Helmadol 400 mg/20ml
Homogeneous syrupy suspension of white color with brownish tint, banana odor and taste 20 ml (400 mg of albendazole) is in dark glass vial. 
1 vial with a leaflet and dosage cap is in a carton box.
 
SALES TERMS
Sold under a prescription.

Home      |      Site Map      |      Terms of Use      |      Privacy Policy

© 2011 World Medicine. All Rights Reserved.